Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
International journal of molecular sciences
2024
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/39769205/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1868266258163564544 |
|---|---|
| author | Zhang, Yunfang Wu, Wei Shi, Yan Huang, Yuehong Dai, Ting Ke, Lina Chen, Lizhu Chen, Mingliang Wang, Qin |
| author_facet | Zhang, Yunfang Wu, Wei Shi, Yan Huang, Yuehong Dai, Ting Ke, Lina Chen, Lizhu Chen, Mingliang Wang, Qin Zhang, Yunfang Wu, Wei Shi, Yan Huang, Yuehong Dai, Ting Ke, Lina Chen, Lizhu Chen, Mingliang Wang, Qin |
| collection | PubMed - marine biology |
| contents | Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells. Zhang, Yunfang Wu, Wei Shi, Yan Huang, Yuehong Dai, Ting Ke, Lina Chen, Lizhu Chen, Mingliang Wang, Qin Humans Cholangiocarcinoma Cell Proliferation Apoptosis Ivermectin Cell Line, Tumor Bile Duct Neoplasms Cell Movement Reactive Oxygen Species Antineoplastic Agents Gene Expression Regulation, Neoplastic Cholangiocarcinoma is a malignant tumor that emerges in the intrahepatic or extrahepatic bile ducts. Doramectin (DOR), a third-generation derivative of avermectins (AVMs), is renowned for its low toxicity and high efficiency. However, no research has hitherto focused on the anti-cholangiocarcinoma effects of these drugs. In this study, we undertook a preliminary exploration of the mechanism through which DOR inhibits the viability of human cholangiocarcinoma cells (Mz-ChA-1) via transcriptome analysis and molecular validation at the cellular level. The results indicated that DOR could suppress the growth and proliferation of Mz-ChA-1 cells in a dose-dependent manner. Moreover, it significantly diminished their migration and invasion abilities. Cell cycle analysis disclosed arrest in the G1 phase, accompanied by an increase in p21 expression and a decrease in the levels of the cyclin E1 and CDK2 proteins. Additionally, DOR induced apoptosis via the ROS-triggered mitochondrial pathway. This was attested by an elevation in the BAX/BCL-2 ratio, the activation of caspase 3/7 and the cleavage of PARP1. These mechanistic insights underscore DOR's potential as a therapeutic agent against cholangiocarcinoma. |
| format | Artículo científico |
| id | pubmed_39769205 |
| institution | PubMed |
| language | en |
| publishDate | 2024 |
| publisher | International journal of molecular sciences |
| record_format | pubmed |
| spellingShingle | Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells. Zhang, Yunfang Wu, Wei Shi, Yan Huang, Yuehong Dai, Ting Ke, Lina Chen, Lizhu Chen, Mingliang Wang, Qin Humans Cholangiocarcinoma Cell Proliferation Apoptosis Ivermectin Cell Line, Tumor Bile Duct Neoplasms Cell Movement Reactive Oxygen Species Antineoplastic Agents Gene Expression Regulation, Neoplastic Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells. Zhang, Yunfang Wu, Wei Shi, Yan Huang, Yuehong Dai, Ting Ke, Lina Chen, Lizhu Chen, Mingliang Wang, Qin Humans Cholangiocarcinoma Cell Proliferation Apoptosis Ivermectin Cell Line, Tumor Bile Duct Neoplasms Cell Movement Reactive Oxygen Species Antineoplastic Agents Gene Expression Regulation, Neoplastic Cholangiocarcinoma is a malignant tumor that emerges in the intrahepatic or extrahepatic bile ducts. Doramectin (DOR), a third-generation derivative of avermectins (AVMs), is renowned for its low toxicity and high efficiency. However, no research has hitherto focused on the anti-cholangiocarcinoma effects of these drugs. In this study, we undertook a preliminary exploration of the mechanism through which DOR inhibits the viability of human cholangiocarcinoma cells (Mz-ChA-1) via transcriptome analysis and molecular validation at the cellular level. The results indicated that DOR could suppress the growth and proliferation of Mz-ChA-1 cells in a dose-dependent manner. Moreover, it significantly diminished their migration and invasion abilities. Cell cycle analysis disclosed arrest in the G1 phase, accompanied by an increase in p21 expression and a decrease in the levels of the cyclin E1 and CDK2 proteins. Additionally, DOR induced apoptosis via the ROS-triggered mitochondrial pathway. This was attested by an elevation in the BAX/BCL-2 ratio, the activation of caspase 3/7 and the cleavage of PARP1. These mechanistic insights underscore DOR's potential as a therapeutic agent against cholangiocarcinoma. |
| title | Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells. |
| topic | Humans Cholangiocarcinoma Cell Proliferation Apoptosis Ivermectin Cell Line, Tumor Bile Duct Neoplasms Cell Movement Reactive Oxygen Species Antineoplastic Agents Gene Expression Regulation, Neoplastic |
| url | https://pubmed.ncbi.nlm.nih.gov/39769205/ |